Skip to main content
Top
Published in: International Journal of Hematology 1/2008

01-01-2008 | Case Report

Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocytopenia and complex imaging features

Authors: Shinichi Kobayashi, Fumihiko Kimura, Yukihiro Hama, Kazuto Ogura, Hiroki Torikai, Ayako Kobayashi, Takashi Ikeda, Ken Sato, Shinsuke Aida, Shigeru Kosuda, Kazuo Motoyoshi

Published in: International Journal of Hematology | Issue 1/2008

Login to get access

Abstract

Histiocytic sarcoma of the spleen, in which the malignant cells display morphologic and immunophenotypic features similar to those of mature tissue histiocytes, is a rare but potentially lethal condition that can remain asymptomatic or only mildly symptomatic for a long period of time. We studied a case of histiocytic sarcoma of the spleen in an 82-year-old woman with prolonged chronic thrombocytopenia that was non-responsive to steroid therapy. Ultrasonography, computed tomography, and magnetic resonance imaging showed a characteristically enlarged spleen and liver. Palliative irradiation therapy was clinically effective; however, disease progression proved lethal. Autopsy revealed the proliferation of tumor cells within the splenic sinus and the liver sinusoids, which displayed extreme hemophagocytosis and strong expression of the histiocytic markers CD68 (KP1 and PG-M1) and CD163. The postmortem diagnosis showed histiocytic sarcoma of the spleen with liver infiltration. This and previous reports indicate that early detection (facilitated by imaging and clinical features) and management may improve patient prognosis and survival. Histiocytic sarcoma of the spleen should be considered as a differential diagnosis in therapeutically unresponsive patients with chronic thrombocytopenia.
Literature
1.
go back to reference Jaffe E. Histiocytic and dendritic cell neoplasms. In: Jaffe ESHN, Stein H, Vardiman JW, editors. World health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. pp. 273–7. Jaffe E. Histiocytic and dendritic cell neoplasms. In: Jaffe ESHN, Stein H, Vardiman JW, editors. World health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2001. pp. 273–7.
2.
go back to reference Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the international lymphoma study group based on 61 cases. Histopathology. 2002;41(1):1–29.PubMedCrossRef Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the international lymphoma study group based on 61 cases. Histopathology. 2002;41(1):1–29.PubMedCrossRef
3.
go back to reference Kimura H, Nasu K, Sakai C, et al. Histiocytic sarcoma of the spleen associated with hypoalbuminemia, hypo-gamma-globulinemia and thrombocytopenia as a possibly unique clinical entity—report of three cases. Leuk Lymphoma. 1998;31(1–2):217–24.PubMed Kimura H, Nasu K, Sakai C, et al. Histiocytic sarcoma of the spleen associated with hypoalbuminemia, hypo-gamma-globulinemia and thrombocytopenia as a possibly unique clinical entity—report of three cases. Leuk Lymphoma. 1998;31(1–2):217–24.PubMed
4.
go back to reference Audouin J, Vercelli-Retta J, Le Tourneau A, et al. Primary histiocytic sarcoma of the spleen associated with erythrophagocytic histiocytosis. Pathol Res Pract. 2003;199(2):107–12.PubMedCrossRef Audouin J, Vercelli-Retta J, Le Tourneau A, et al. Primary histiocytic sarcoma of the spleen associated with erythrophagocytic histiocytosis. Pathol Res Pract. 2003;199(2):107–12.PubMedCrossRef
5.
go back to reference Franchino C, Reich C, Distenfeld A, Ubriaco A, Knowles DM. A clinicopathologically distinctive primary splenic histiocytic neoplasm. Demonstration of its histiocyte derivation by immunophenotypic and molecular genetic analysis. Am J Surg Pathol. 1988;12(5):398–404.PubMedCrossRef Franchino C, Reich C, Distenfeld A, Ubriaco A, Knowles DM. A clinicopathologically distinctive primary splenic histiocytic neoplasm. Demonstration of its histiocyte derivation by immunophenotypic and molecular genetic analysis. Am J Surg Pathol. 1988;12(5):398–404.PubMedCrossRef
6.
go back to reference Vos JA, Abbondanzo SL, Barekman CL, Andriko JW, Miettinen M, Aguilera NS. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005;18(5):693–704.PubMedCrossRef Vos JA, Abbondanzo SL, Barekman CL, Andriko JW, Miettinen M, Aguilera NS. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005;18(5):693–704.PubMedCrossRef
7.
go back to reference Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol. 2005;29(5):617–24.PubMedCrossRef Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam Y. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol. 2005;29(5):617–24.PubMedCrossRef
8.
go back to reference Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol. 2004;122(5):794–801.PubMedCrossRef Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol. 2004;122(5):794–801.PubMedCrossRef
9.
go back to reference Mikami M, Sadahira Y, Suetsugu Y, Wada H, Sugihara T. Monocyte/Macrophage-specific marker CD163+ histiocytic sarcoma: case report with clinical, morphologic, immunohistochemical, and molecular genetic studies. Int J Hematol. 2004;80(4):365–9.PubMedCrossRef Mikami M, Sadahira Y, Suetsugu Y, Wada H, Sugihara T. Monocyte/Macrophage-specific marker CD163+ histiocytic sarcoma: case report with clinical, morphologic, immunohistochemical, and molecular genetic studies. Int J Hematol. 2004;80(4):365–9.PubMedCrossRef
10.
go back to reference Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28(9):1133–44.PubMedCrossRef Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28(9):1133–44.PubMedCrossRef
11.
go back to reference Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. RadioGraphics. 2004;24(4):1137–63.PubMedCrossRef Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. RadioGraphics. 2004;24(4):1137–63.PubMedCrossRef
12.
go back to reference Levy AD, Abbott RM, Abbondanzo SL. Littoral cell angioma of the spleen: CT features with clinicopathologic comparison. Radiology. 2004;230(2):485–90.PubMedCrossRef Levy AD, Abbott RM, Abbondanzo SL. Littoral cell angioma of the spleen: CT features with clinicopathologic comparison. Radiology. 2004;230(2):485–90.PubMedCrossRef
13.
go back to reference Ramani M, Reinhold C, Semelka RC, et al. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology. 1997;202(1):166–72.PubMed Ramani M, Reinhold C, Semelka RC, et al. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology. 1997;202(1):166–72.PubMed
Metadata
Title
Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocytopenia and complex imaging features
Authors
Shinichi Kobayashi
Fumihiko Kimura
Yukihiro Hama
Kazuto Ogura
Hiroki Torikai
Ayako Kobayashi
Takashi Ikeda
Ken Sato
Shinsuke Aida
Shigeru Kosuda
Kazuo Motoyoshi
Publication date
01-01-2008
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2008
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-007-0008-9

Other articles of this Issue 1/2008

International Journal of Hematology 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine